To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03754179
Title Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma (COMBI-R2)
Acronym COMBI-R2
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Universitair Ziekenhuis Brussel
Indications
Therapies
Age Groups: senior | adult
Covered Countries BEL

Facility Status City State Zip Country Details
UZ Brussel RECRUITING Jette Brabant 1090 Belgium Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field